GlassScriptPhysician profile
Syed H Mohiuddin
NPI 1295185163
$23,203.62
in general payments reported to CMS, 2019-2025
11 companies · $2,025 in 2025
The $2,025 reported for 2025 was more than what 83% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,566 · 2020: $15K · 2022: $294 · 2024: $14.54 · 2025: $2,025.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,480 · Food and Beverage: $560.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,480.01 |
| Food and Beverage | $560.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $10,525.28 | 2019-2020 | |
| Stryker Corporation | $6,446.04 | 2019-2025 | Hoffmann, N/A, Easyfuse |
| Cdc Medical LLC | $2,615.00 | 2019-2020 | |
| Medline Industries LP | $1,496.58 | 2019 | |
| Vilex LLC | $1,158.53 | 2025 | Redemption |
| Core Surgical Group | $641.57 | 2024-2025 | |
| Paragon 28, INC. | $155.47 | 2019-2022 | |
| Arteriocyte Medical Systems, INC. | $103.23 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $23.56 | 2019 | |
| Acera Surgical, INC. | $22.31 | 2019 | |
| Medical Device Business Services, INC. | $16.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Mohiuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.